The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
GABA system dysfunction in autism and related disorders: From synapse to symptoms
Open accessAbstract
Autism Spectrum Disorders (ASDs) are neurodevelopmental syndromes characterised by repetitive behaviours and restricted interests, impairments in social behavior and relations, and in language and communication. These symptoms are also observed in a number of developmental disorders of known origin, including Fragile X Syndrome, Rett syndrome, and Fetal Anticonvulsant Syndrome. While these conditions have diverse etiologies, and poorly understood pathologies, emerging evidence suggests that they may all be linked to dysfunction in particular aspects of GABAergic inhibitory signalling in the brain. We review evidence from genetics, molecular neurobiology and systems neuroscience relating to the role of GABA in these conditions. We conclude by discussing how these deficits may relate to the specific symptoms observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Structural variation in the human genome
Feuk, L., Carson, A. R., & Scherer, S. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1767 · Cited by 2,034
Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H. (2011) · Nature · doi:10.1038/nature10110 · Cited by 1,874
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., et al. (2012) · Nature · doi:10.1038/nature11011 · Cited by 1,734
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Rare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
De Novo Gene Disruptions in Children on the Autistic Spectrum
Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B., Lee, Y.-H., Narzisi, G., Leotta, A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.04.009 · Cited by 1,446
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes
Chao, H.-T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., Neul, J. L., Gong, S., Lu, H.-C., Heintz, N., et al. (2010) · Nature · doi:10.1038/nature09582 · Cited by 1,168
A clinicopathological study of autism
Bailey, A. (1998) · Brain · doi:10.1093/brain/121.5.889 · Cited by 1,083
Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075
Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis
Chudley, A. E. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040302 · Cited by 987
Behavioral Alterations in Rats Prenatally Exposed to Valproic Acid: Animal Model of Autism
Schneider, T., & Przewłocki, R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300518 · Cited by 959
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Molecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Molecular Structure and Physiological Functions of GABABReceptors
Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00036.2003 · Cited by 924
Prevalence of autism-spectrum conditions: UK school-based population study
Baron-Cohen, S., Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E., & Brayne, C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.059345 · Cited by 918
Epidemiology of Autism Spectrum Disorders in Adults in the Community in England
Brugha, T. S., McManus, S., Bankart, J., Scott, F., Purdon, S., Smith, J., Bebbington, P., Jenkins, R., & Meltzer, H. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.38 · Cited by 903
Diagnosis and definition of childhood autism
Rutter, M. (1978) · Journal of Autism and Childhood Schizophrenia · doi:10.1007/bf01537863 · Cited by 750
Carlén, M., Meletis, K., Siegle, J. H., Cardin, J. A., Futai, K., Vierling-Claassen, D., Rühlmann, C., Jones, S. R., Deisseroth, K., Sheng, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.31 · Cited by 669
The Teratogenicity of Anticonvulsant Drugs
Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., & Ryan, L. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441504 · Cited by 655
Dani, V. S., Chang, Q., Maffei, A., Turrigiano, G. G., Jaenisch, R., & Nelson, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506071102 · Cited by 639
Fetal Alcohol Spectrum Disorders: An Overview with Emphasis on Changes in Brain and Behavior
Riley, E. P., & McGee, C. L. (2005) · Experimental Biology and Medicine · doi:10.1177/15353702-0323006-03 · Cited by 627
A genome-wide linkage and association scan reveals novel loci for autism
The Gene Discovery Project of Johns Hopkins & the Autism Consortium, Weiss, L. A., & Arking, D. E. (2009) · Nature · doi:10.1038/nature08490 · Cited by 619
Autism spectrum disorders and autistic traits: A decade of new twin studies
Ronald, A., & Hoekstra, R. A. (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31159 · Cited by 616
Common circuit defect of excitatory-inhibitory balance in mouse models of autism
Gogolla, N., LeBlanc, J. J., Quast, K. B., Südhof, T. C., Fagiolini, M., & Hensch, T. K. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9023-x · Cited by 610
Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F., Raiteri, M., Bonner, T. I., & Enna, S. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.247 · Cited by 601
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585
Knoll, J. H. M., Nicholls, R. D., Magenis, R. E., Graham, J. M., Lalande, M., Latt, S. A., Opitz, J. M., & Reynolds, J. F. (1989) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320320235 · Cited by 576
Evidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Muthukumaraswamy, S. D., Edden, R. A. E., Jones, D. K., Swettenham, J. B., & Singh, K. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900728106 · Cited by 567
A clinical study of 57 children with fetal anticonvulsant syndromes
Moore, S. J., Turnpenny, P., Quinn, A., Glover, S., Lloyd, D. J., Montgomery, T., & Dean, J. C. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.7.489 · Cited by 562
Trace fear conditioning involves hippocampal α 5 GABA A receptors
Crestani, F., Keist, R., Fritschy, J.-M., Benke, D., Vogt, K., Prut, L., Blüthmann, H., Möhler, H., & Rudolph, U. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142288699 · Cited by 528
Neuropathological findings in autism
Palmen, S. J. M. C. (2004) · Brain · doi:10.1093/brain/awh287 · Cited by 527
Rudolph, U., & Möhler, H. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121429 · Cited by 519
Postmortem brain abnormalities of the glutamate neurotransmitter system in autism
Purcell, A. E., Jeon, O. H., Zimmerman, A. W., Blue, M. E., & Pevsner, J. (2001) · Neurology · doi:10.1212/wnl.57.9.1618 · Cited by 518
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome
Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 515
Dictenberg, J. B., Swanger, S. A., Antar, L. N., Singer, R. H., & Bassell, G. J. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.04.003 · Cited by 511
Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
Rothman, D. L., Petroff, O. A., Behar, K. L., & Mattson, R. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5662 · Cited by 509
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
Amiet, C., Gourfinkel-An, I., Bouzamondo, A., Tordjman, S., Baulac, M., Lechat, P., Mottron, L., & Cohen, D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.030 · Cited by 499
Specific GABA A Circuits for Visual Cortical Plasticity
Fagiolini, M., Fritschy, J.-M., Löw, K., Möhler, H., Rudolph, U., & Hensch, T. K. (2004) · Science · doi:10.1126/science.1091032 · Cited by 471
Characteristics of fetal anticonvulsant syndrome associated autistic disorder
Rasalam, A., Hailey, H., Williams, J., Moore, S., Turnpenny, P., Lloyd, D., & Dean, J. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205001076 · Cited by 456
GABAA Receptor Trafficking-Mediated Plasticity of Inhibitory Synapses
Luscher, B., Fuchs, T., & Kilpatrick, C. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.024 · Cited by 434
The role of GABAA receptors in the acute and chronic effects of ethanol: a decade of progress
Kumar, S., Porcu, P., Werner, D. F., Matthews, D. B., Diaz-Granados, J. L., Helfand, R. S., & Morrow, A. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1562-z · Cited by 431
Guilmatre, A., Dubourg, C., Mosca, A.-L., Legallic, S., Goldenberg, A., Drouin-Garraud, V., Layet, V., Rosier, A., Briault, S., Bonnet-Brilhault, F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.80 · Cited by 429
Fetal valproate syndrome and autism: additional evidence of an association
Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B., & Hersh, J. H. (2001) · Developmental Medicine and Child Neurology · doi:10.1017/s001216220100038x · Cited by 422
Samaco, R. C., Hogart, A., & LaSalle, J. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi045 · Cited by 421
The temporal binding deficit hypothesis of autism
BROCK, J., BROWN, C. C., BOUCHER, J., & RIPPON, G. (2002) · Development and Psychopathology · doi:10.1017/s0954579402002018 · Cited by 419
COGNITIVE DEFICITS IN THE PATHOGENESIS OF AUTISM*
Rutter, M. (1983) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1983.tb00129.x · Cited by 403
Stagg, C. J., Bestmann, S., Constantinescu, A. O., Moreno Moreno, L., Allman, C., Mekle, R., Woolrich, M., Near, J., Johansen‐Berg, H., & Rothwell, J. C. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.216978 · Cited by 401
Autism Profiles of Males With Fragile X Syndrome
Harris, S. W., Hessl, D., Goodlin-Jones, B., Ferranti, J., Bacalman, S., Barbato, I., Tassone, F., Hagerman, P. J., Herman, K., & Hagerman, R. J. (2008) · American Journal on Mental Retardation · doi:10.1352/2008.113:427-438 · Cited by 396
Fine Mapping of Autistic Disorder to Chromosome 15q11-q13 by Use of Phenotypic Subtypes
Shao, Y., Cuccaro, M. L., Hauser, E. R., Raiford, K. L., Menold, M. M., Wolpert, C. M., Ravan, S. A., Elston, L., Decena, K., Donnelly, S. L., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367846 · Cited by 382
Ingram, J. L., Peckham, S. M., Tisdale, B., & Rodier, P. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(99)00083-5 · Cited by 381
Transport of Glutamate and Other Amino Acids at the Blood-Brain Barrier
Smith, Q. R. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1016s · Cited by 381
Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation
Clifford, S., Dissanayake, C., Bui, Q. M., Huggins, R., Taylor, A. K., & Loesch, D. Z. (2007) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0205-z · Cited by 377
Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers
Cook, E. H., Courchesne, R. Y., Cox, N. J., Lord, C., Gonen, D., Guter, S. J., Lincoln, A., Nix, K., Haas, R., Leventhal, B. L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301832 · Cited by 369
Consciousness and the Binding Problem
SINGER, W. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05712.x · Cited by 367
GABAA receptor diversity and pharmacology
Möhler, H. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0284-3 · Cited by 363
Age of diagnosis for autism: individual and community factors across 10 birth cohorts
Fountain, C., King, M. D., & Bearman, P. S. (2011) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2009.104588 · Cited by 359
Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP
Hatton, D. D., Sideris, J., Skinner, M., Mankowski, J., Bailey, D. B., Roberts, J., & Mirrett, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31286 · Cited by 359
A Systematic Review of Medical Treatments for Children With Autism Spectrum Disorders
McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N., & Veenstra-VanderWeele, J. (2011) · Pediatrics · doi:10.1542/peds.2011-0427 · Cited by 356
Ma, D. Q., Whitehead, P. L., Menold, M. M., Martin, E. R., Ashley-Koch, A. E., Mei, H., Ritchie, M. D., DeLong, G. R., Abramson, R. K., Wright, H. H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/433195 · Cited by 354
Epigenetics of autism spectrum disorders
Schanen, N. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl213 · Cited by 341
New insights into the role of the GABAA–benzodiazepine receptor in psychiatric disorder
Nutt, D. J., & Malizia, A. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.5.390 · Cited by 339
Self-citationDisruption in the Inhibitory Architecture of the Cell Minicolumn: Implications for Autisim
Casanova, M. F., Buxhoeveden, D., & Gomez, J. (2003) · The Neuroscientist · doi:10.1177/1073858403253552 · Cited by 336
Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1013238809666 · Cited by 322
Association between a GABRB3 polymorphism and autism
Buxbaum, J. D., Silverman, J. M., Smith, C. J., Greenberg, D. A., Kilifarski, M., Reichert, J., Cook Jr, E. H., Fang, Y., Song, C.-Y., & Vitale, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001011 · Cited by 321
Alterations of GABAergic Signaling in Autism Spectrum Disorders
Pizzarelli, R., & Cherubini, E. (2011) · Neural Plasticity · doi:10.1155/2011/297153 · Cited by 321
Decreased expression of the GABAA receptor in fragile X syndrome
D'Hulst, C., De Geest, N., Reeve, S. P., Van Dam, D., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.115 · Cited by 318
Validating γ oscillations and delayed auditory responses as translational biomarkers of autism
Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.031 · Cited by 314
Olmos-Serrano, J. L., Paluszkiewicz, S. M., Martin, B. S., Kaufmann, W. E., Corbin, J. G., & Huntsman, M. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1714-10.2010 · Cited by 309
Gaetz, W., Edgar, J. C., Wang, D. J., & Roberts, T. P. L. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.077 · Cited by 307
Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications
Yip, J., Soghomonian, J.-J., & Blatt, G. J. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0176-3 · Cited by 303
Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.
Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Badner, J. A., Matsui, S., Conroy, J., McQuaid, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.009 · Cited by 299
Neuronal activity is required for the development of specific cortical interneuron subtypes
De Marco García, N. V., Karayannis, T., & Fishell, G. (2011) · Nature · doi:10.1038/nature09865 · Cited by 294
The critical period of valproate exposure to induce autistic symptoms in Sprague–Dawley rats
Kim, K. C., Kim, P., Go, H. S., Choi, C. S., Yang, S.-I., Cheong, J. H., Shin, C. Y., & Ko, K. H. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.018 · Cited by 284
Epilepsy in autism: features and correlates
Bolton, P. F., Carcani-Rathwell, I., Hutton, J., Goode, S., Howlin, P., & Rutter, M. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076877 · Cited by 281
Whitney, E. R., Kemper, T. L., Bauman, M. L., Rosene, D. L., & Blatt, G. J. (2008) · The Cerebellum · doi:10.1007/s12311-008-0043-y · Cited by 268
Gulyás, A. I., Szabó, G. G., Ulbert, I., Holderith, N., Monyer, H., Erdélyi, F., Szabó, G., Freund, T. F., & Hájos, N. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4104-10.2010 · Cited by 262
Mutations in GABAAreceptor subunits associated with genetic epilepsies
Macdonald, R. L., Kang, J.-Q., & Gallagher, M. J. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.186999 · Cited by 262
The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities
Wisniewski, K. E., Segan, S. M., Miezejeski, C. M., Sersen, E. A., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380267 · Cited by 261
Bolton, P. F., Dennis, N. R., Browne, C. E., Thomas, N. S., Veltman, M. W. M., Thompson, R. J., & Jacobs, P. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1551 · Cited by 246
Selby, L., Zhang, C., & Sun, Q.-Q. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.062 · Cited by 245
Autism Spectrum Disorders and Epigenetics
Grafodatskaya, D., Chung, B., Szatmari, P., & Weksberg, R. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.005 · Cited by 235
Increased serum levels of glutamate in adult patients with autism
Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., Sekine, Y., Suda, S., Suzuki, K., Sugihara, G.-I., et al. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.013 · Cited by 234
Identification of MeCP2 mutations in a series of females with autistic disorder
Carney, R. M., Wolpert, C. M., Ravan, S. A., Shahbazian, M., Ashley-Koch, A., Cuccaro, M. L., Vance, J. M., & Pericak-Vance, M. A. (2003) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00624-0 · Cited by 233
Hogart, A., Nagarajan, R. P., Patzel, K. A., Yasui, D. H., & LaSalle, J. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm014 · Cited by 233
Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., & Matsuda, T. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1065-0 · Cited by 231
Early Defects of GABAergic Synapses in the Brain Stem of a MeCP2 Mouse Model of Rett Syndrome
Medrihan, L., Tantalaki, E., Aramuni, G., Sargsyan, V., Dudanova, I., Missler, M., & Zhang, W. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00826.2007 · Cited by 229
Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients
Sadakata, T., Washida, M., Iwayama, Y., Shoji, S., Sato, Y., Ohkura, T., Katoh-Semba, R., Nakajima, M., Sekine, Y., Tanaka, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29031 · Cited by 218
Downregulation of Tonic GABAergic Inhibition in a Mouse Model of Fragile X Syndrome
Curia, G., Papouin, T., Séguéla, P., & Avoli, M. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn159 · Cited by 218
Rowlett, J. K., Platt, D. M., Lelas, S., Atack, J. R., & Dawson, G. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405621102 · Cited by 212
Decreased GABAA receptor expression in the seizure-prone fragile X mouse
El Idrissi, A., Ding, X.-H., Scalia, J., Trenkner, E., Brown, W. T., & Dobkin, C. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.087 · Cited by 210
Genetics of autistic disorders: review and clinical implications
Freitag, C. M., Staal, W., Klauck, S. M., Duketis, E., & Waltes, R. (2010) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0076-x · Cited by 208
Prenatal Alcohol Exposure and Neurodevelopmental Disorders in Children Adopted From Eastern Europe
Landgren, M., Svensson, L., Strömland, K., & Andersson Grönlund, M. (2010) · Pediatrics · doi:10.1542/peds.2009-0712 · Cited by 199
Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism
Shimmura, C., Suda, S., Tsuchiya, K. J., Hashimoto, K., Ohno, K., Matsuzaki, H., Iwata, K., Matsumoto, K., Wakuda, T., Kameno, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025340 · Cited by 189
Plasma amino acid levels in children with autism and their families
Aldred, S., Moore, K. M., Fitzgerald, M., & Waring, R. H. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1022238706604 · Cited by 188
Genetics and Function of Neocortical GABAergic Interneurons in Neurodevelopmental Disorders
Rossignol, E. (2011) · Neural Plasticity · doi:10.1155/2011/649325 · Cited by 188
Late Development of the GABAergic System in the Human Cerebral Cortex and White Matter
Xu, G., Broadbelt, K. G., Haynes, R. L., Folkerth, R. D., Borenstein, N. S., Belliveau, R. A., Trachtenberg, F. L., Volpe, J. J., & Kinney, H. C. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822f471c · Cited by 187
Oblak, A., Gibbs, T. T., & Blatt, G. J. (2009) · Autism Research · doi:10.1002/aur.88 · Cited by 184
Page, L., Daly, E., Schmitz, N., Simmons, A., Toal, F., Deeley, Q., Ambery, F., McAlonan, G. M., Murphy, K. C., & Murphy, D. G. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2189 · Cited by 180
Self-citationFragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176
Association Analysis of Chromosome 15 GABAAReceptor Subunit Genes in Autistic Disorder
Menold, M. M., Shao, Y., Wolpert, C. M., Donnelly, S. L., Raiford, K. L., Martin, E. R., Ravan, S. A., Abramson, R. K., Wright, H. H., Delong, G. R., et al. (2001) · Journal of Neurogenetics · doi:10.3109/01677060109167380 · Cited by 175
Oblak, A. L., Gibbs, T. T., & Blatt, G. J. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.021 · Cited by 175
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171
CNTNAP2 variants affect early language development in the general population
Whitehouse, A. J. O., Bishop, D. V. M., Ang, Q. W., Pennell, C. E., & Fisher, S. E. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00684.x · Cited by 170
Fetal exposure to teratogens: Evidence of genes involved in autism
Dufour-Rainfray, D., Vourc’h, P., Tourlet, S., Guilloteau, D., Chalon, S., & Andres, C. R. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.013 · Cited by 167
Solving the Autism Puzzle a Few Pieces at a Time
Schaaf, C. P., & Zoghbi, H. Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.025 · Cited by 166
The GABAA receptor: a novel target for treatment of fragile X?
D’Hulst, C., & Kooy, R. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.003 · Cited by 166
Downregulation of Parvalbumin at Cortical GABA Synapses Reduces Network Gamma Oscillatory Activity
Volman, V., Behrens, M. M., & Sejnowski, T. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3041-11.2011 · Cited by 164
D'Hulst, C., Heulens, I., Brouwer, J. R., Willemsen, R., De Geest, N., Reeve, S. P., De Deyn, P. P., Hassan, B. A., & Kooy, R. F. (2009) · Brain Research · doi:10.1016/j.brainres.2008.11.075 · Cited by 164
McCauley, J. L., Olson, L. M., Delahanty, R., Amin, T., Nurmi, E. L., Organ, E. L., Jacobs, M. M., Folstein, S. E., Haines, J. L., & Sutcliffe, J. S. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30038 · Cited by 160
Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome
Lam, C. W., YEUNG, W.-L., KO, C.-H., POON, P. M. K., TONG, S.-F., CHAN, K.-Y., Lo, I. F. M., CHAN, L. Y. S., HUI, J., WONG, V., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.12.e41 · Cited by 150
Evidence for Cortical Dysfunction in Autism: A Proton Magnetic Resonance Spectroscopic Imaging Study
DeVito, T. J., Drost, D. J., Neufeld, R. W. J., Rajakumar, N., Pavlosky, W. F., Williamson, P., & Nicolson, R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.022 · Cited by 145
Bishop, S., Gahagan, S., & Lord, C. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01782.x · Cited by 143
Dhossche, D. M., Applegate, H., Abraham, A., Maertens, P. M., Bland, L., Bencsath, A. F., & Martinez, J. (2002) · PubMed · Cited by 141
Méndez, M. A., Horder, J., Myers, J., Coghlan, S., Stokes, P. R. A., Erritzøe, D., Howes, O. D., Lingford-Hughes, A. R., Murphy, D., & Nutt, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.008 · Cited by 140
Self-citationThe SLC32 transporter, a key protein for the synaptic release of inhibitory amino acids
Gasnier, B. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1091-2 · Cited by 140
Gray and White Matter Brain Chemistry in Young Children With Autism
Friedman, S. D., Shaw, D., Artru, A. A., Dawson, G., Petropoulos, H., & Dager, S. R. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.7.786 · Cited by 140
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Fatemi, S. H., Folsom, T. D., Kneeland, R. E., & Liesch, S. B. (2011) · The Anatomical Record · doi:10.1002/ar.21299 · Cited by 137
Pacey, L. K. K., Heximer, S. P., & Hampson, D. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056127 · Cited by 133
Synaptic and extrasynaptic GABA transporters as targets for anti‐epileptic drugs
Madsen, K. K., Clausen, R. P., Larsson, O. M., Krogsgaard‐Larsen, P., Schousboe, A., & White, H. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05982.x · Cited by 133
AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
Levenga, J., Hayashi, S., de Vrij, F. M. S., Koekkoek, S. K. E., van der Linde, H. C., Nieuwenhuizen, I. M., Song, C., Buijsen, R. A. M., Pop, A. S., Gomez‐Mancilla, B., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.022 · Cited by 132
Maternal transmission of a rare GABRB3 signal peptide variant is associated with autism
Delahanty, R., Kang, J., Brune, C. W., Kistner, E. O., Courchesne, E., Cox, N. J., Cook, E. H., Macdonald, R. L., & Sutcliffe, J. S. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.118 · Cited by 132
Reduced transcript expression of genes affected by inherited and de novo CNVs in autism
STAART Psychopharmacology Network, Nord, A. S., Roeb, W., Dickel, D. E., Walsh, T., Kusenda, M., O’Connor, K. L., Malhotra, D., McCarthy, S., Stray, S. M., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.24 · Cited by 129
Altered Development of Glutamate and GABA Receptors in the Basal Ganglia of Girls with Rett Syndrome
Blue, M. E., Naidu, S., & Johnston, M. V. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7030 · Cited by 128
GABAergic Interneuron Development and Function Is Modulated by the Tsc1 Gene
Fu, C., Cawthon, B., Clinkscales, W. B., Bruce, A., Winzenburger, P. A., & Ess, K. C. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr300 · Cited by 126
James, S. J., Melnyk, S., Jernigan, S., Pavliv, O., Trusty, T. A., Lehman, S. L., Seidel, L., Gaylor, D. W., & Cleves, M. A. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31094 · Cited by 125
Reliability of Long-Interval Cortical Inhibition in Healthy Human Subjects: A TMS–EEG Study
Farzan, F., Barr, M. S., LEVINSON, A. J., Chen, R. E., Wong, W., Fitzgerald, P. B., & Daskalakis, Z. J. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00279.2010 · Cited by 123
Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1
Gregor, A., Albrecht, B., Bader, I., Bijlsma, E. K., Ekici, A. B., Engels, H., Hackmann, K., Horn, D., Hoyer, J., Klapecki, J., et al. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-106 · Cited by 121
Expression Pattern of the Rett Syndrome Gene MeCP2 in Primate Prefrontal Cortex
Akbarian, S., Chen, R. Z., Gribnau, J. H., Rasmussen, T. P., Fong, H., Jaenisch, R., & Jones, E. G. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0420 · Cited by 121
Impaired inhibitory control of cortical synchronization in fragile X syndrome
Paluszkiewicz, S. M., Olmos-Serrano, J. L., Corbin, J. G., & Huntsman, M. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00421.2011 · Cited by 118
Long-range GABAergic connections distributed throughout the neocortex and their possible function
Tamamaki, N., & Tomioka, R. (2010) · Frontiers in Neuroscience · doi:10.3389/fnins.2010.00202 · Cited by 116
Oliver, C., Berg, K., Moss, J. F., Arron, K., & Burbidge, C. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1125-5 · Cited by 115
Serotonin and amino acid content in platelets of autistic children
Rolf, L. H., Haarmann, F. Y., Grotemeyer, K. ‐., & Kehrer, H. E. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03378.x · Cited by 113
Sharma, A., & Shaw, S. R. (2011) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2011.02.008 · Cited by 111
Plasma excitatory amino acids in autism.
Moreno-Fuenmayor, H., Borjas, L., Arrieta, A. J., Valera, & Socorro-Candanoza, L. (1996) · PubMed · Cited by 109
Oberman, L. M., Ifert-Miller, F., Najib, U., Bashir, S., Woollacott, I., Gonzalez–Heydrich, J., Picker, J. D., Rotenberg, A., & Pascual‐Leone, Á. (2010) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2010.00026 · Cited by 106
Development of amino acid receptors in frontal cortex from girls with Rett syndrome
Blue, M. E., Naidu, S., & Johnston, M. V. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199904)45:4<541::aid-ana21>3.0.co;2-2 · Cited by 104
Predictors of seizure onset in Rett syndrome
Jian, L., Nagarajan, L., de Klerk, N. H., Ravine, D., Bower, C. I., Anderson, A., Williamson, S. L., Christodoulou, J., & Leonard, H. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.06.015 · Cited by 104
Rett syndrome: the complex nature of a monogenic disease
Renieri, A., Meloni, I., Longo, I., Ariani, F., Mari, F., Pescucci, C., & Cambi, F. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0444-9 · Cited by 99
Collinson, N., Atack, J. R., Laughton, P., Dawson, G. R., & Stephens, D. N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0361-z · Cited by 98
Durant, C. F., Christmas, D. M., & Nutt, D. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_8 · Cited by 93
Self-citationEnticott, P. G., Rinehart, N., Tonge, B. J., Bradshaw, J. L., & Fitzgerald, P. B. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03665.x · Cited by 92
Carrasco, M., Volkmar, F. R., & Bloch, M. H. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3285 · Cited by 92
Stein, M. B., Yang, B.-Z., Chavira, D. A., Hitchcock, C. A., Sung, S. C., Shipon-Blum, E., & Gelernter, J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.008 · Cited by 89
Pringsheim, T. M., Lam, D., & Patten, S. B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0145 · Cited by 86
Evaluation of the GABAergic nervous system in autistic brain: 123I-iomazenil SPECT study
Mori, T., Mori, K., Fujii, E., Toda, Y., Miyazaki, M., Harada, M., Hashimoto, T., & Kagami, S. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.10.007 · Cited by 85
Portera‐Cailliau, C. (2011) · The Neuroscientist · doi:10.1177/1073858410395322 · Cited by 82
MeCP2 Is Required for Normal Development of GABAergic Circuits in the Thalamus
Zhang, Z., Zak, J. D., & Liu, H. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00601.2009 · Cited by 81
Enticott, P. G., Kennedy, H. A., Rinehart, N., Tonge, B. J., Bradshaw, J. L., & Fitzgerald, P. B. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.017 · Cited by 81
Efficient γ‐aminobutyric acid editing at 3T without macromolecule contamination: MEGA‐SPECIAL
Near, J., Simpson, R., Cowen, P. J., & Jezzard, P. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1688 · Cited by 80
Eliasen, M., Tolstrup, J. S., Nybo Andersen, A.-M., Gronbaek, M., Olsen, J., & Strandberg-Larsen, K. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq056 · Cited by 72
Involvement of cholinergic and gabaergic systems in the fragile X knockout mice
D’Antuono, M., Merlo, D., & Avoli, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00103-9 · Cited by 71
El-Ansary, A. K., Bacha, A. B., & Ayahdi, L. Y. A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.06.982 · Cited by 64
Sibilla, S., & Ballerini, L. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.06.001 · Cited by 61
Meguro‐Horike, M., Yasui, D. H., Powell, W. T., Schroeder, D. I., Oshimura, M., LaSalle, J. M., & Horike, S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr298 · Cited by 61
The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.
Sgadó, P., Dunleavy, M., Genovesi, S., Provenzano, G., & Bozzi, Y. (2011) · PubMed · Cited by 59
Perry, T. L., Dunn, H. G., Ho, H. H., & Crichton, J. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80060-x · Cited by 55
An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder
Erickson, C. A., Early, M. C., Stigler, K. A., Wink, L. K., Mullett, J. E., & McDougle, C. J. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0034 · Cited by 55
Lingford-Hughes, A. R., Reid, A. G., Myers, J. F., Feeney, A., Hammers, A., Taylor, L. G., Rosso, L., Turkheimer, F., Brooks, D. J., Grasby, P. M., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379509 · Cited by 53
Self-citationThanseem, I., Anitha, A., Nakamura, K., Suda, S., Iwata, K., Matsuzaki, H., Ohtsubo, M., Ueki, T., Katayama, T., Iwata, Y., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.020 · Cited by 52
Eagleson, K. L., Gravielle, M. C., Schlueter, L. J., Russek, S. J., Farb, D. H., & Levitt, P. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.066 · Cited by 41
Is connexin36 critical for GABAergic hypersynchronization in the hippocampus?
Beaumont, M. A., & Maccaferri, G. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201491 · Cited by 40
Regulation of Excitation by GABA Neurotransmission: Focus on Metabolism and Transport
Madsen, K. K., Larsson, O. M., & Schousboe, A. (2007) · Springer eBooks · doi:10.1007/400_2007_036 · Cited by 38
Gruß, M., & Braun, K. A. (2001) · Neural Plasticity · doi:10.1155/np.2001.285 · Cited by 35
Decrease in benzodiazepine receptor binding in the brains of adult patients with Rett syndrome
Yamashita, Y., Matsuishi, T., Ishibashi, M., Kimura, A., Onishi, Y., Yonekura, Y., & Kato, H. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00223-2 · Cited by 34
Downregulation of GABAA β Subunits is Transcriptionally Controlled by Fmr1p
Hong, A., Zhang, A., Ke, Y., Idrissi, A. E., & Shen, C.-H. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9531-5 · Cited by 33
Stephan, D. A. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.003 · Cited by 29
Erratum: Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K., Simone, A., Jou, J., Gelboin-Burkhart, C. A., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D. X., et al. (2011) · Nature · doi:10.1038/nature10603 · Cited by 17
Simon, E. W., Haas‐Givler, B., & Finucane, B. M. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31000 · Cited by 12
Turner (1996) · doi:10.1002/(sici)1096-8628(19960712)64:1<196::aid-ajmg35>3.0.co;2-g
Cited by
Ferguson, B. R., & Gao, W.-J. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00037 · Cited by 594
Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516
“Around 20% of those with FXS meet formal criteria for an ASD [239-242] and 25% exhibit epileptic symptoms [243], thus implicating FMR1 both as an autism susceptibility gene and a regulator of cortical inhibitory function.”
BackgroundCosta, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
Influence of maternal thyroid hormones during gestation on fetal brain development
Moog, N. K., Entringer, S., Heim, C., Wadhwa, P. D., Kathmann, N., & Buss, C. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.070 · Cited by 474
Gephyrin: a master regulator of neuronal function?
Tyagarajan, S. K., & Fritschy, J.-M. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3670 · Cited by 425
Metadata
- Authors
- Coghlan, S., Horder, J., Inkster, B., Mendez, M. A., Murphy, D. G., & Nutt, D. J.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 36
- Issue
- 9
- Pages
- 2044-2055
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2038596292
- Cited by
- 446
- References
- 183
- FWCI
- 13.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.